News & Press Releases
NEWS
Saturn TMVR System in Eurointervention
Eurointervention, the official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), published preclinical data on our novel, investigational Saturn TMVR device in the article Procedural performance and healing response...
Animation of the Saturn TMVR System Trans-septal Procedure
🎥 Watch our animation that showcases the trans-septal implant procedure of the Saturn TMVR system here. The Saturn device has a 29 French Valve Delivery System and 2 valve sizes (28 and 31mm) designed to anchor to the native mitral valve through a subannular ring at...
InnovHeart CEO on DeviceTalks Weekly Podcast
David Wilson, CEO of InnovHeart, was interviewed by Tom Salemi, Editorial Director on DeviceTalks Weekly Podcast in the February 23, 2024 weekly edition. In this podcast, David talks about his journey into Medtech, his decision to shift from R&D and commercial to...
Presentation of Saturn at PCR London Valve – November 2023
Our technology and transapical clinical results have been presented at 2023 PCR London Valve held on November 24-26 in Excel Center, London, UK. Specifically, Dr. Paolo Denti, MD held a presentation named "the Saturn TMVR Trans-apical FHU study: Two-year Trans-apical...
InnovHeart Featured in MedTech Strategist
We are pleased to announce that InnovHeart is featured in the MedTech Strategist October 2023 edition. The article "The Tantalizing Mitral Valve Device Market” by author Mary Stuart captures well InnovHeart’s commitment to enhancing the quality of life for millions of...
PRESS RELEASES
InnovHeart appoints David Wilson as Chief Executive Officer
Industry Leader to Guide Company and the Saturn TMVR Programin its Next Phase of Growth InnovHeart s.r.l. announced today the appointment of David James Wilson, an experienced healthcare and medical device executive as Chief Executive Officer of the company and...
InnovHeart raises $55 million in Series C financing to further develop the Trans-septal Saturn Transcatheter Mitral Valve Replacement System
InnovHeart and Grand Pharmaceutical Group Enter Into an Exclusive License Agreement to Develop and Commercialize the Saturn TMVR Device in Greater China Milan, January 27, 2022 - InnovHeart s.r.l. announces the closing of its Series C financing with granting an...
Azin Parhizgar, Ph.D. Joins InnovHeart as Independent Member of the Board of Directors
InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of Mitral Regurgitation, announced today the appointment of successful serial entrepreneur and medical device executive Dr. Azin Parhizgar, Ph.D. as an...
InnovHeart Reports Successful First-in- Human Implantation of its Saturn Transcatheter Mitral Valve with Excellent 30-day Follow-up
InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of Mitral Regurgitation (MR), announced today the successful Firstin-Human implantation of its proprietary Saturn Transcatheter Mitral Valve along with...
Transcatheter Mitral Valve Replacement Company InnovHeart Closes Series B Financing of €20 Million
InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral valve disease, announced today the closing of a €20 million round of equity financing. Founded in 2015 by Giovanni Righini, a 30-year veteran of...